ArticleFrontiers in artificial intelligence2025
XAI-BT-EdgeNet: explainable edge-aware deep learning with squeeze-and-excitation for brain tumor detection and prediction.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- StrokeCT-2C5K: A Two-Center Cranial CT Dataset for Four-Class Stroke Classification Using SE-Attention-Enhanced Deep Learning Models.Biomimetics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate and early detection of brain tumors is critical for effective treatment and improved patient outcomes, yet manual radiological analysis remains time-consuming, subjective, and error-prone. To address these challenges and improve clinical trust in AI systems, this study presents XAI-BT-EdgeNet, an explainable, edge-aware deep learning framework integrated with squeeze-and-excitation (SE) modules for brain tumor detection using MRI scans. Methods: The proposed architecture employs a dual-branch design that fuses high-level semantic features from InceptionV3 with low-level edge representations via an Edge Feature Block, while SE modules adaptively recalibrate feature importance to enhance diagnostic accuracy. To ensure transparency, the model incorporates four XAI techniques-LIME, Grad-CAM, Grad-CAM++, and Vanilla Saliency-which provide interpretable visual justifications for predictions. The framework was trained and evaluated on the Brain Tumor Dataset by Preet Viradiya, comprising 4,589 labeled MRI images divided into Brain Tumor (2,513) and Healthy (2,076) classes. Results: The model achieved 99.58% training accuracy, 99.71% validation accuracy, and 100.00% testing accuracy, alongside minimal loss values of 0.0103, 0.0051, and 0.0026, respectively. These results demonstrate the robustness and precision of the proposed framework in brain tumor classification. Discussion: This work includes the development of a dual-branch CNN architecture that combines semantic and edge features for enhanced classification, the integration of SE modules to highlight clinically significant regions, and the application of multi-method XAI to offer transparent, interpretable outputs for clinical applicability. Overall, XAI-BT-EdgeNet delivers a high-performing, interpretable solution that bridges the gap between deep learning and trustworthy clinical decision-making in brain tumor diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.